Experiment 565334

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationMALFETANO,JH: BLESSING,JA: HOMESLEY,HD: LOOK,KY: MC GHEE,R:. (1996). A PHASE II TRIAL OF DIDEMNIN B (NSC #335319) IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE CERVIX.. 19(2)
Amount utilized
Compound isolated
DiseasePHASE II STUDY OF 26 PATIENTS CERVIX CANCER MAXIMUM TOXICITY.
Dose amount6.30 MG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitSQ M
Dose expressionDOSE
GenderFEMALE